| Literature DB >> 29900150 |
Monica Navarro-Meza1,2, Karina Anai Garcia-Camacho2, Felipe Santoyotelles3, Antonio López-Espinoza2, Omar Arroyo-Helguera4.
Abstract
Entities:
Year: 2018 PMID: 29900150 PMCID: PMC5996326
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
Demographic and clinical characteristics in adults with Type 2 Diabetes Mellitus
| Age(yr), Mean± SD | 49.94 ± 10.64 | Glucose, mg/dl, mean±SD | 173.09 ± 74.69 |
| Women | 25 (74) | Glucose, mg/dl, <60 | 0 |
| Men | 9 (26) | Glucose, mg/dl, 60–110 | 3 (10) |
| BMI, (kg/m2) Mean± SD | 29.63 ± 4.40 | Glucose, mg/dl, >110 | 28 (90) |
| Low weight | 0 | Total cholesterol, mg/dl, mean±SD | 174.04 ± 41.63 |
| Normal weight | 6 (18) | Total cholesterol, mg/dl, <200 | 21 (67.7) |
| Overweight | 15 (44) | Total cholesterol, mg/dl, 200–239 | 8 (25.8) |
| Obesity type I | 9 (26) | Total cholesterol, mg/dl, >249 | 2 (6.5) |
| Obesity type II | 4 (12) | Cholesterol LDL, mg/dl, mean ± SD | 106.50 ± 27.87 |
| Civil status (Single) | 5 (15) | Cholesterol LDL, mg/dl, <100 | 11 (32) |
| Civil status (Marriage) | 22(64) | Cholesterol LDL, mg/dl, 100–129 | 14 (41) |
| Civil status (Widower) | 3(9) | Cholesterol LDL, mg/dl, 130–160 | 6 (18) |
| Civil status (Divorced) | 2(6) | Cholesterol HDL, mg/dl, mean ± SD | 45.14 ± 11.23 |
| Civil status (Free Union) | 2(9) | Cholesterol HDL, mg/dl, Men>50 | 0 |
| Education Primary | 10 (29) | Cholesterol HDL, mg/dl, Men 35–50 | 1 (3) |
| Education Middle School | 10 (29) | Cholesterol HDL, mg/dl, Men<35 | 8 (26) |
| Education High School | 5 (15) | Cholesterol HDL, mg/dl, Women>60 | 0 |
| Education Other | 8 (24) | Cholesterol HDL, mg/dl, Women 45–60 | 15 (16) |
| Education No studies | 1 (3) | Cholesterol HDL, mg/dl, Women<45 | 17 (55) |
| Physical activity (Yes) | 13 (38) | Insulin, μU/ml, mean ± SD | 54.75 ± 21.47 |
| Physical activity (No) | 21(62) | Insulin, μU/ml, 0.7–25 | 1 (3) |
| Comorbidities (Arterial hypertension) | 13 (38) | Insulin, μU/ml, >25 | 29 (97) |
| Comorbidities (None) | 21 (62) | Interleucin-6 (pg/ml) | 499 ±116 |
| Drug consumption <3 | 25 (74) | Antioxidant capacity (mM uric acid equivalent) | 0.061±0.09 |
| Drug consumption >3 | 1 (3) | ||
| No Drug consumption | 8 (23) |
Note: Drugs consumed are: metformin and glibenclamide, insulin, antihypertensives, acetylsalicylic acid, statins: atorvastatin, cinnarizine, anticonvulsant/antineuralgic: pregabalin, and non-steroidal anti-inflammatory